Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2 publications
UV1 plus pembrolizumab in recurrent and metastatic head and neck squamous cell carcinoma: safe, immunogenic, but lacking efficacy.
Journal: Translational cancer research
Published: December 01, 2025
Newly identified invasion drivers define the tumor front in oral squamous cell carcinoma.
Journal: Cell death discovery
Published: September 16, 2025
Showing 1-2 of 2
Last Updated: 09/26/2026